n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with 3-hydroxybenzylhydrazine in 1 studies
Studies (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Trials (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Recent Studies (post-2010) (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Studies (3-hydroxybenzylhydrazine) | Trials (3-hydroxybenzylhydrazine) | Recent Studies (post-2010) (3-hydroxybenzylhydrazine) |
---|---|---|---|---|---|
14 | 0 | 0 | 273 | 0 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldessarini, RJ; Huston-Lyons, D; Marsh, ER | 1 |
1 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and 3-hydroxybenzylhydrazine
Article | Year |
---|---|
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Topics: 4-Butyrolactone; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Extrapyramidal Tracts; Hydrazines; Limbic System; Male; Rats; Rats, Sprague-Dawley | 1994 |